Significant decrease in plasmad‐dimer levels and mean platelet volume after a 3‐month treatment with rosuvastatin in patients with venous thromboembolism

BACKGROUND: Inflammation has been considered as a possible mechanism for the initiation and recurrence of venous thromboembolism (VTE). Statins have anti‐inflammatory and potential immune‐modulatory effects, but their effect on plasmad‐dimer levels is controversial. HYPOTHESIS: In this study, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Alirezaei, Toktam, Sattari, Haniyeh, Irilouzadian, Rana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286331/
https://www.ncbi.nlm.nih.gov/pubmed/35481712
http://dx.doi.org/10.1002/clc.23833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286331/
https://www.ncbi.nlm.nih.gov/pubmed/35481712
http://dx.doi.org/10.1002/clc.23833

Ejemplares similares